• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模型指导下的促生长激素释放激素对生长激素的前馈刺激的定量分析。

Model informed quantification of the feed-forward stimulation of growth hormone by growth hormone-releasing hormone.

机构信息

Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.

Centre for Human Drug Research, Leiden, The Netherlands.

出版信息

Br J Clin Pharmacol. 2020 Aug;86(8):1575-1584. doi: 10.1111/bcp.14265. Epub 2020 Mar 9.

DOI:10.1111/bcp.14265
PMID:32087619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7373696/
Abstract

AIMS

Growth hormone (GH) secretion is pulsatile and secretion varies highly between individuals. To understand and ultimately predict GH secretion, it is important to first delineate and quantify the interaction and variability in the biological processes underlying stimulated GH secretion. This study reports on the development of a population nonlinear mixed effects model for GH stimulation, incorporating individual GH kinetics and the stimulation of GH by GH-releasing hormone (GHRH).

METHODS

Literature data on the systemic circulation, the median eminence, and the anterior pituitary were included as system parameters in the model. Population parameters were estimated on data from 8 healthy normal weight and 16 obese women who received a 33 μg recombinant human GH dose. The next day, a bolus injection of 100 μg GHRH was given to stimulate GH secretion.

RESULTS

The GH kinetics were best described with the addition of 2 distribution compartments with a bodyweight dependent clearance (increasing linearly from 24.7 L/h for a 60-kg subject to 32.1 L/h for a 100-kg subject). The model described the data adequately with high parameter precision and significant interindividual variability on the GH clearance and distribution volume. Additionally, high variability in the amount of secreted GH, driven by GHRH receptor activation, was identified (coefficient of variation = 90%).

CONCLUSION

The stimulation of GH by GHRH was quantified and significant interindividual variability was identified on multiple parameters. This model sets the stage for further development of by inclusion of additional physiological components to quantify GH secretion in humans.

摘要

目的

生长激素(GH)的分泌呈脉冲式,个体间的分泌差异很大。为了理解并最终预测 GH 的分泌,首先明确和量化刺激 GH 分泌的基础生物学过程的相互作用和可变性非常重要。本研究报告了一种用于 GH 刺激的群体非线性混合效应模型的开发,该模型结合了个体 GH 动力学和 GH 释放激素(GHRH)对 GH 的刺激。

方法

将文献中关于全身循环、中脑和垂体前叶的数据作为模型的系统参数进行了纳入。对 8 名健康正常体重和 16 名肥胖女性接受 33μg 重组人生长激素剂量的数据进行了群体参数估计。第二天,给予 100μg GHRH 冲击注射以刺激 GH 分泌。

结果

通过增加 2 个分布室并使清除率与体重相关(从 60kg 受试者的 24.7L/h 线性增加到 100kg 受试者的 32.1L/h),GH 动力学得到了最佳描述。该模型能够充分描述数据,具有较高的参数精度和 GH 清除率和分布容积的显著个体间可变性。此外,还确定了由 GHRH 受体激活驱动的分泌 GH 量的高度可变性(变异系数=90%)。

结论

对 GHRH 刺激 GH 的作用进行了量化,并确定了多个参数的显著个体间可变性。该模型为进一步发展包括其他生理成分以定量人体 GH 分泌奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b7f/7373696/de3fef5807a0/BCP-86-1575-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b7f/7373696/052870e73415/BCP-86-1575-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b7f/7373696/f2feba8beb2d/BCP-86-1575-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b7f/7373696/e77a7fa64df1/BCP-86-1575-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b7f/7373696/de3fef5807a0/BCP-86-1575-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b7f/7373696/052870e73415/BCP-86-1575-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b7f/7373696/f2feba8beb2d/BCP-86-1575-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b7f/7373696/e77a7fa64df1/BCP-86-1575-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b7f/7373696/de3fef5807a0/BCP-86-1575-g004.jpg

相似文献

1
Model informed quantification of the feed-forward stimulation of growth hormone by growth hormone-releasing hormone.模型指导下的促生长激素释放激素对生长激素的前馈刺激的定量分析。
Br J Clin Pharmacol. 2020 Aug;86(8):1575-1584. doi: 10.1111/bcp.14265. Epub 2020 Mar 9.
2
Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.连续24小时静脉输注重组人生长激素释放激素(1-44)酰胺,在绝经后女性处于雌激素缺乏和雌激素补充状态时,均能增强脉冲式、熵性和每日节律性生长激素分泌。
J Clin Endocrinol Metab. 2001 Feb;86(2):700-12. doi: 10.1210/jcem.86.2.7195.
3
Estradiol supplementation enhances submaximal feed-forward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu.在假定生长抑素缺乏的环境中,补充雌二醇可增强重组人生长激素释放激素-1,44-酰胺对生长激素(GH)分泌的次最大前馈驱动作用。
J Clin Endocrinol Metab. 2003 Nov;88(11):5484-9. doi: 10.1210/jc.2003-030410.
4
The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.生长激素释放激素序贯给药,120分钟后再给予司坦瑞林,作为评估人体垂体生长激素储备的有效试验。
Clin Endocrinol (Oxf). 1996 Nov;45(5):543-51. doi: 10.1046/j.1365-2265.1996.00841.x.
5
Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.重组人胰岛素样生长因子I给药对人体生长激素(GH)分泌的影响,包括自发分泌以及由生长激素释放激素或六肽促生长激素释放肽(一种肽类GH促分泌素)刺激后的分泌。
J Clin Endocrinol Metab. 1999 Jan;84(1):285-90. doi: 10.1210/jcem.84.1.5386.
6
The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.危重症中的生长激素轴:持续输注生长激素释放激素和生长激素释放肽-2的影响
J Clin Endocrinol Metab. 1997 Feb;82(2):590-9. doi: 10.1210/jcem.82.2.3736.
7
Effects of cholinergic muscarinic blockade on growth hormone responses to growth hormone-releasing hormone in uraemic patients.胆碱能毒蕈碱阻断对尿毒症患者生长激素释放激素刺激生长激素反应的影响。
Nephrol Dial Transplant. 1999 Jul;14(7):1704-9. doi: 10.1093/ndt/14.7.1704.
8
The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men.搏动性给药、持续输注以及昼夜变化对正常男性生长激素(GH)释放激素的生长激素(GH)反应的影响。
J Clin Endocrinol Metab. 1986 Oct;63(4):872-8. doi: 10.1210/jcem-63-4-872.
9
Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion.禁食和培维索孟对生长激素释放激素和生长激素释放肽-6刺激的生长激素分泌的影响。
Clin Endocrinol (Oxf). 2001 Oct;55(4):461-7. doi: 10.1046/j.1365-2265.2001.01374.x.
10
Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.年龄、体脂百分比和血清睾酮浓度对男性生长激素释放激素三日静脉脉冲输注后生长激素、胰岛素样生长因子-I(IGF-I)及IGF结合蛋白反应的影响不均。
Eur J Endocrinol. 1998 Jul;139(1):59-71. doi: 10.1530/eje.0.1390059.

引用本文的文献

1
Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results.奥曲肽口腔胶囊治疗肢端肥大症:两项 3 期临床试验结果比较。
Pituitary. 2021 Dec;24(6):943-953. doi: 10.1007/s11102-021-01163-2. Epub 2021 Jun 25.

本文引用的文献

1
Use of a Systems Pharmacology Model Based Approach Toward Dose Optimization of Parathyroid Hormone Therapy in Hypoparathyroidism.基于系统药理学模型方法优化甲状旁腺功能减退症甲状旁腺激素治疗的剂量。
Clin Pharmacol Ther. 2019 Mar;105(3):710-718. doi: 10.1002/cpt.1200. Epub 2018 Oct 22.
2
How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review.生长激素和胰岛素样生长因子-1 如何作为临床肢端肥大症研究中药物有效性的标志物报告?全面的方法学综述。
Pituitary. 2018 Jun;21(3):310-322. doi: 10.1007/s11102-018-0884-4.
3
Plurihormonal cells of normal anterior pituitary: Facts and conclusions.
正常垂体前叶的多激素细胞:事实与结论。
Oncotarget. 2017 Apr 25;8(17):29282-29299. doi: 10.18632/oncotarget.16502.
4
Biochemical investigations in diagnosis and follow up of acromegaly.肢端肥大症诊断与随访中的生化检查
Pituitary. 2017 Feb;20(1):33-45. doi: 10.1007/s11102-017-0792-z.
5
Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics.连续数据药代动力学模型的模型评估:指标与图形
CPT Pharmacometrics Syst Pharmacol. 2017 Feb;6(2):87-109. doi: 10.1002/psp4.12161. Epub 2017 Feb 10.
6
Quantitative Systems Pharmacology: A Framework for Context.定量系统药理学:一种情境框架。
Curr Pharmacol Rep. 2016 Jun;2(3):152-160. doi: 10.1007/s40495-016-0058-x. Epub 2016 Apr 8.
7
Anatomy of the Ophthalmic Artery: A Review concerning Its Modern Surgical and Clinical Applications.眼动脉的解剖:关于其现代外科手术及临床应用的综述
Anat Res Int. 2015;2015:591961. doi: 10.1155/2015/591961. Epub 2015 Nov 9.
8
Blood flow distribution in cerebral arteries.脑动脉中的血流分布。
J Cereb Blood Flow Metab. 2015 Mar 31;35(4):648-54. doi: 10.1038/jcbfm.2014.241.
9
Basic concepts in population modeling, simulation, and model-based drug development: part 3-introduction to pharmacodynamic modeling methods.群体建模、模拟和基于模型的药物研发的基本概念:第 3 部分——药效学建模方法介绍。
CPT Pharmacometrics Syst Pharmacol. 2014 Jan 2;3(1):e88. doi: 10.1038/psp.2013.71.
10
Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data.在药代动力学建模中结合“自下而上”和“自上而下”方法:将生理药代动力学(PBPK)模型与观察到的临床数据进行拟合。
Br J Clin Pharmacol. 2015 Jan;79(1):48-55. doi: 10.1111/bcp.12234.